ARCHIVED - The Presidential Early Career Award for Scientists and Engineers (PECASE) Program Archive

WE ARE PLEASED TO ACKNOWLEDGE THE NIH RECIPIENTS FROM PREVIOUS YEARS:

    [2014]    [2013]   [2012]    [2011]    [2010]    [2009]    [2008]    [2007]    [2006]    [2005]    [2004]    [2003]    [2002]    [2001]    [2000]    [1999]    [1998]    [1997]    [1996]

 

2014
 

Dr. Gregory Alushin (Rockefeller University) DP5OD017885

Dr. Manish Arora (Icahn School of Medicine at Mount Sinai) DP2ES025453

Dr. Dawn Cornelison (University of Missouri) R01AR067450

Dr. Craig Duvall (Vanderbilt University) R01EB019409

Dr. Nicholas Gilpin (Louisiana State University Health Sciences Center) R01AA023305

Dr. Anna Greka (Brigham and Women's Hospital) R01DK095045

Dr. Pamela Guerrerio (National Institutes of Health, National Institute of Allergy and Infectious Diseases) ZIAAI001202

Dr. Christine Hendon (Columbia University) DP2HL127776

Dr. Catherine Karr (University of Washington) R01ES023510

Dr. Maria Lehtinen (Boston Children's Hospital) R01NS088566

Dr. Adriana Lleras-Muney (University of California, Los Angeles) R01HD077227

Dr. Mary Kay Lobo (University of Maryland School of Medicine) R01DA038613

Dr. Michael McAlpine (University of Minnesota) DP2EB020537

Dr. Eric Morrow (Brown University) R01MH105442

Dr. Daniel O'Connor (Johns Hopkins University) R01NS089652

Dr. Aimee Shen (Tufts University) R01GM108684

Dr. Cui Tao (University of Texas) R01LM011829

Dr. Jacquelyn Taylor (Yale School of Nursing) R01NR013520

Dr. Benjamin Voight (University of Pennsylvania) R01DK101478

Dr. Blake Wiedenheft (Montana State University) R01GM108888

2013
 

Dr. Hillel Adesnik (University of California, Berkeley) 1DP2NS087725-01 
For studies on cortical function and neurological disorders.

Dr. Samantha Brugmann (Cincinnati Children’s Hospital Medical Center) 1R01DE023804-01 
For studies on the developmental processes essential to craniofacial development.

Dr. Namandje Bumpus (Johns Hopkins University) 1R01GM103853-01 
For studies to investigate the mechanisms underlying the hepatotoxicity of antiretroviral drugs.

Dr. Kafui Dzirasa (Duke University) 1R01MH099192-01 
For studies of large scale neural network interactions that may shed light on the pathophysiology of affective disorders.

Dr. Camilla Forsberg (University of California, Santa Cruz) 1R01DK100917-01 
For studies to understand the mechanisms that regulate stem cell fate decisions.

Dr. Tina Goldstein (University of Pittsburgh) 1R01MH100056-01A 
For studies to develop and test therapies for adolescents with bipolar disorder to target mood symptoms and suicidality.

Dr. Viviana Gradinaru (California Institute of Technology) 1DP2NS087949-01 
For studies on the architecture of neuron-communication in the brain.

Dr. Jordan J. Green (Johns Hopkins University) 1R01EB016721-01 
For studies to develop nanoparticles for delivery of therapeutic DNA to brain cancer cells.

Dr. Katie Kindt (National Institute on Deafness and Other Communication Disorders) 1ZIADC000085-01 
For studies on disorders in mechanosensation, such as hearing, balance, and touch.

Dr. Andre Larochelle (National Heart, Lung, and Blood Institute) 1ZIAHL006172-01 
For studies on regenerative therapies for inherited blood disorders.

Dr. Jennifer Lorvick (Research Triangle Institute International) 1R01MD007679-01 
For studies to understand how criminal justice involvement contributes to health disparities among illicit drug using African American women.

Dr. Courtney Miller (The Scripps Research Institute) 1R01DA034116-01A1 
For studies on the prevention of substance abuse relapse triggered by drug-associated memory.

Dr. Kiran Musunuru (Harvard University) 1R01HL118744-01 
For studies to understand the genetics of cardiovascular disease.

Dr. David J. Pagliarini (University of Wisconsin- Madison) 1R01DK098672-01 
For studies to examine the mitochondrial proteome during the development of obesity and diabetes.

Dr. Sachin Patel (Vanderbilt University) 1R01MH100096-01 
For studies on the treatment of anxiety and post-traumatic stress disorders.

Dr. Amy Ralston (Michigan State University) 1R01GM104009-01A1 
For studies to reveal insight into mammalian early development and stem cell establishment.

Dr. Ervin Sejdic (University of Pittsburgh) 1R01HD074819-01 
For studies to address a significant problem in those suffering from stroke, namely Dysphagia (or swallowing impairment).

Dr. Elizabeth Skidmore (University of Pittsburgh) 1R01HD074693-01A1 
For studies to examine the influences of cognitive and affective impairments on neurorehabilitation outcomes.

Dr. Kay Maxine Tye (Massachusetts Institute of Technology) 1DP2DK102256-01 
For studies to develop and apply methods to decipher and manipulate the neural circuitry underlying compulsive sugar intake to ameliorate behaviors leading to obesity.

Dr. Muhammad Walji (The University of Texas Health Science Center Houston) 1R01DE022628-01A1
For studies to improve the usability of electronic health records to mitigate critical use errors that may harm patients.

2012
 

Dr. Debra Auguste (City College of New York) 1DP2CA174495-01 For research on personalized therapeutics for inhibiting breast cancer metastasis 
Dr. Jeremy Clark (University of Washington) 5R01AA021121-02 For studies of neural mechanisms of risk preference following adolescent alcohol exposure 
Dr. Damien Fair (Oregon Health and Science University) 5R01MH096773-02 For studies characterizing mechanistic heterogeneity across ADHD and Autism 
Dr. Thomas Fazzio (University of Massachusetts Medical School) 5R01HD072122-02 For work on elucidating the roles of chromatin regulation in embryonic stem cell self-renewal 
Dr. Jessica Gill (National Institute of Nursing Research, National Institutes of Health) 1ZIANR000027-01 For an investigation of the predictors of neurological deficits and PTSD onset following TBI 
Dr. Andrew Goodman (Yale University School of Medicine) 1DP2GM105456-01 For research on defining the causes and consequences of interpersonal microbial variation 
Dr. Xue Han (Boston University) 1DP2NS082126-01 For research on light-actuatable nanorobots for molecular uncaging 
Dr. Susan Harbison (National Heart Lung and Blood Institute, National Institutes of Health) 1ZIAHL006147-02 For studies on the impact of drugs on genetic networks affecting sleep 
Dr. Richard Ho (Vanderbilt University Medical Center) 5R01GM099924-02 For studies of hepatic OATP drug transporters and chemotherapy disposition 
Dr. Shingo Kajimura (University of California at San Francisco) 5R01DK097441-02 For studies on molecular control of brown adipose cell fate and energy metabolism 
Dr. Young Kim (Yale University School of Medicine) 5R01ES021462-02 For studying the roles of environmental risks and GEX in increasing Autism Spectrum Disorder (ASD) prevalence 
Dr. Todd Macfarlan (Eunice Kennedy Shriver National Institute on Child Health and Human Development, National Institutes of Health) 1ZIAHD008933-01 For research on mechanisms of mammalian epigenome reprogramming 
Dr. Gaby Maimon (Rockefeller University) 1DP2DA035148-01 For work on linking genes to higher brain function by way of cellular electrophysiology 
Dr. Sandra McAllister (Harvard Medical School) 5R01CA166284-02 For studies to understand how breast cancers activate and respond to the systemic environment
Dr. Quyen Nguyen (University of California at San Diego) 5R01EB014929-02 For testing fluorescently labeled probes for nerve imaging during surgery 
Dr. Sallie Permar (Duke University School of Medicine) 1DP2HD075699-01 For studies of maternal immune protection against congenital CMV infection 
Dr. Katherine Radek (Loyola University Chicago) 5R01AR061497-02 For studies linking nicotinic activation with skin innate immunity and atopic dermatitis 
Dr. Katherine Rauen (University of California at San Francisco) 5R01AR062165-02 For studies on the role of germline mutations in the Ras/MAPK pathway on skeletal myogenesis 
Dr. Ida Spruill (Medical University of South Carolina) 5R01NR012432-02 For work on ethno-cultural barriers to health literacy and disease management in African Americans 
Dr. Andrew Yoo (Washington University School of Medicine) 1DP2NS083372-01 For studies of microRNA and neural factor-mediated direct reprogramming of cell fates

2011
Dr. Nihal Altan-Bonne Rutgers University 1R01AI091985-01A1 For research identifying a common lipid blueprint for viral replication and potential panviral therapeutics.
Dr. Peter Crompton National Institute of Allergy and Infectious Diseases1ZIAAI001155-01 For studies on the mechanisms of naturally-Acquired immunity to malaria.
Dr. Margherita R. Fontana University of Michigan School of Dentistry 1U01DE021412-01A1 For studies on the ability to predict caries risk for underserved toddlers in primary health care settings. 
Dr. Ervin R. Fox University of Mississippi Medical Center 1 R01 HL104184-01A1 For studies on the clinical and genetic correlates of vascular function in African Americans.
Dr. Valerie Horsley Yale University R01-AR060295-01A1For studies on the extrinsic regulation of epidermal homeostasis.
Dr. Steven T. Kosak Northwestern University Feinberg School of Medicine 1 DP2 OD008717-01 For studies on the organization of vertebrate genomes.
Dr. Erica N. Larschan Brown University 1 R01 GM98461-01 For studies of coordinate gene regulation during Drosophila dosage compensation.
Dr. Daniel Larson National Cancer Institute 1ZIABC011383-01 For studies on transcription dynamics of single human cells.
Dr. Erez Lieberman-Aiden Harvard University 1 DP2 OD008540-01 For studies exploring how the genome folds through proximity ligation and sequencing.
Dr. Krista M. Lisdahl University of Wisconsin - Milwaukee 1 R01 DA030354-01 For studies on the effects of physical activity & marijuana use on frontolimbic function in teens.
Dr. Emanual M. Maverakis University of California 1 DP2 OD008752-01 For studies on the development of new therapeutic avenues for scleroderma. 
Dr. Jay Zachary. Parrish University of Washington 1 R01 NS076614-01 For studies on the extrinsic signals required to maintain dendrite coverage.
Dr. Biju Parekkadan Massachusetts General Hospital and Harvard Medical School 1-R01-EB012521-01A1 For studies on bioengineered human stem cell niches.
Dr. Peter P. Reese University of Pennsylvania R01 DK090388-01 For innovative work on ethical approaches to expanding access to organ transplantation.
Dr. Niels Ringstad Skirball Institute, New York University School of Medicine 1R01 GM098320-01 For studies on the mechanisms of modulation of serotonin signaling.
Dr. Pawan Sinha Massachusetts Institute of Technology 1 R01 EY020517-01 For studies on the age-related development of object perception.
Dr. Georgios Skiniotis University of Michigan 1R01DK090165-01 For studies on the structure and function of signaling cell-surface receptors.
Dr. Beth Stevens F.M. Kirby Neurobiology Center, Boston Children's Hospital 1 R01 NS071008-01A1 For studies on the role of glia and immune molecules in synapse elimination.
Dr. Justin Taraska National Heart, Lung, and Blood Institute 1ZIAHL006098-01 For studies on the architecture and control of vesicle fusion in excitable cells.
Dr. Brendan M. Walker Washington State University 1 R01AA020394-01 For studies on the role of dynorphin / kappa-opioid systems in alcohol dependence.